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Recently there have been gratifying advances in the identification and quanfitation 
of surface antigens on mouse thymocytes, lymphocytes, and leukemia cells (1). These 
cells have been studied more than others from this point of view because they can 
readily be  obtained viable in free  suspension without  the  need for  enzymatic or 
mechanical dispersion. Briefly, this is what is known: 
There are so far three sets of cell surface antigens found only on thymocytes and 
lymphocytes; they are MSLA (mouse specific lymphocyte antigen)  1 (2), a species 
antigen recognized by absorbed rabbit anti-thymocyte and anti-lymphocyte  sera, 
and two genetically unlinked  sets of alloantigens,  Ly-A and Ly-B (3). 
Thymocytes have more of these three antigens than do lymphocytes, and also 
of the  alloantigen 0  (4)  which is  expressed  also  on brain. Information on the 
existence and tissue representation of other alloantigens serologically detectable 
on lymphoid cells is accumulating. 
In those  strains of  mice that  express  TL  antigens (TL  +  strains)  these  are 
restricted to  thymocytes; this absolutely distinguishes the  thymocyte from all 
other lymphocytes in TL  + strains (see reference  1). 
H-2  alloantigens (5),  which occur  on most cell types,  are  present in much 
higher amounts on lymphocytes than on thymocytes, in contrast to all the anti- 
gens mentioned above (1). 
It has long been suspected, on various grounds, that lymphocytes, although they 
are morphologically uniform, are diverse in origin and function. What can we expect 
the study of the surface antigens to tell us about this probable heterogeneity of lympho- 
cytes? To begin with, we know that all or a portion of lymphocytes from different 
anatomical sites share the antigens referred to above. We also recognize  that thymo- 
cyte populations can be distinguished from lymphocyte populations by differences in 
the amount of any one of these antigens, a~well as by the absolute restriction of TL 
antigens to thymocytes. If some lymphocytes are derived from thymocytes, which is 
still a  subject of controversy, considerable remodeling of the cell surface must take 
* The authors'  work is supported in part by National Cancer Institute Grant CA 08748 
and a grant from the John A. Hartford Foundation, Inc. 
~: There may be some debate about the extent to which the terms "plasma cell," "immuno- 
globulin-forming cell," and "hemolytic plaque-forming cell" are interchangeable; throughout 
the text we have used whichever seemed most appropriate in its context. 
1 Abbreviations used in this  paper:  MSLA, mouse specific lymphocyte  antigen;  EBSS, 
Earle's balanced salt solution; PFC, plaque-forming cells; Pca-plasma cell antigen. 
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place in the process, involving loss of TL, decrease of O, Ly-A, Ly-B, and MSLA, and a 
fourfold increase of H-2. The antecedent differentiation of bone marrow stem cells to 
thymocytes involves perhaps an even more extensive revision of surface structure, for 
probably none of these antigens except H-2 is expressed on the stem cell (1). 
Turning  to  the  question  of  cell surface  antigens  expressed  on  malignant  cells, 
leukemias carry four known classes of cell surface antigens: (a)  the normal species 
antigens and aUoantigens already mentioned,  (b) TL antigens coded by derepressed 
Tla genes of the cellular genome, (c) antigens coded by oncogenic viruses, including 
the various leukemia viruses and  a  variant of the mammary tumor virus,  and  (d) 
other  antigens,  such  as  "E,"  whose  specification is not sufficiently clear to permit 
relegation to one of the preceding three categories (6,  7). 
We have proposed elsewhere that TL, 0, Ly-A, Ly-B, and MSLA are "differentia- 
tion" antigens, owing their expression to selective gene action peculiar to lymphoid 
differentiation,  and  that  they  may  serve  as  markers  identifying surface  elements 
necessary to the functional or behavioral properties of the lymphoid cell (1). An im- 
portant extension of this hypothesis is that cell recognition in general is implemented 
by similar surface structural codes, via selective gene action. 
To substantiate this in serological terms at the present time is difficult, mainly be- 
cause other tissues cannot in general be analyzed immunogenetically in quite the same 
way  as  lymphoid cells.  However,  several types  of  malignant cell populations  are 
amenable to many of the relevant procedures, and of these tumors the transplanted 
myeloma (plasma cell tumor) is of special interest because of its suspected but unde- 
fined relation to the thymocyte-lymphocyte axis, about which a great deal is already 
known. 
Despite the handicap of being denied a  homogeneous population of normal 
cells to  work  with  (because  it  is impracticable to  prepare homogeneous  sus- 
pensions of normal viable plasma cells) we have been able to establish a number 
of facts that bear on surface structure in relation to the differentiation of plasma 
cells, normal and malignant, and these are reported here. We set out to investi- 
gate two questions:  (a)  Are the cell surface antigens characteristic of thymo- 
cytes and  lymphocytes expressed  on  plasma  cells?  (b)  Do  plasma  cells have 
their own special cell surface alloantigens? 
Materials and Methods 
Mice.--These  were  obtained either from  our colonies or from  the Jackson Laboratory. 
(Abbreviations: BALB  =  BALB/c; C57BL  =  C57BL/6 except  in reference  to the trans- 
planted C57BL ascites leukemia, EL4, whose subline of origin is not known to us). 
Transplanted Tumors.--Myelomas: See reference 8. Table I identifies the seven transplanted 
plasma cell tumors included in this study. Leukemias and sarcomas: See previous publications 
from this laboratory (9-11). 
Antisera.--(a)  See Table II for antisera used  to identify known  antigens of thymocytes 
and lymphocytes. (b) Antiserum to the BALB  (H-2  d) myeloma MOPC-70A, identifying the 
new alloantigen PC.1  (see  Results), was prepared in female DBA/2 mice (also H-2 d) by three 
or more inoculations  of MOPC-70A,  beginning with 1-5  X  105 viable cells subcutaneously, 
followed 3 wk later by 1-5  X  106 cells subcutaneously  and then 5 X  106 intraperitoneally TOSHITADA  TAKAHASItI,  LLOYD J.  OLD, EDWARD  A.  BOYSE  1327 
at intervals of 3 wk; the recipients were bled from the tail under ether anesthesia 7-10 days 
after the  last inoculation and  their serum pooled.  Erythrocytes  and other host cells were 
largely eliminated from MOPC-70A used for immunization by several cycles of centrifugation 
at 400 rpin for 10 min in an International Centrifuge (Model PR-2, International Equipment 
Co., Needham Heights, Mass.). 
TABLE  I 
The Myelomas 
Description  Mouse strain  Immuno-  Carriedascites  oraS 
of orion  globulin  subcutaneous  Source 
product  transplant 
MOPC-70A  BALB  q'lK  Ascites  ] 
iDrnMinN  Teller,  Sloan-Ketter-  MOPC-104E  "  ~k +  k  Ascites  i  g  stitute 
MPC-67  "  aK  Ascites 
MPC-11  "  "Y2bK  Subcuta-  Dr.  J.  W.  Uhr, New  York  Uni- 
neous  versity 
Adj-PC5  "  y2~K  Subcuta-  Dr.  T.  A.  Conners,  Chester- 
neous  Beatty  Research  Institute 
X5563  C3H/He  q,2~K  Subcuta- 
neous 
MOPC-387  (BALB X  a•  Subcuta- 
DBA/2) F1  neous 
Dr.  M.  Potter,  National  Insti- 
tutes of Health 
TABLE  II 
Antisera Recognizing Surface Antigens on Cells of the Thymocyte-Lymphocyte Axis 
Serum  Cell surface antigens recognized 
C57BL anti B.~LB ascites sarcoma Meth A  H-2 a 
A/TL-  (congenic with A)  anti A strain spontaneous leukemia  TL.1, 2, 3 
ASL1 
AKR anti C3Hf/Bi thymocytes 
DBA/2  anti C57BL  ascites leukemia EL4  (test  cells:  BALB 
thymocytes) 
C57BL/Ly-B.1  (congenic with C57BL)  anti C57BL radiation- 
induced leukemia ERLD 
Rabbit anti A strain thvmocytes, (absorbed in vivo in A strain  MSLA 
mice) 
O-C3H 
Ly-A.2  (on BALB thymo- 
cytes) 
Ly-B.2 
Cell  Suspensions.--(a)  Cells  from  thymus,  lymph  node,  and  spleen  were  obtained  by 
mincing these tissues with curved scissors in a  few drops of Medium  199, the released cells 
having been washed twice before use.  (b) Blood lymphocytes: One part of heparinized blood 
and 3 parts of Plasmagel (Laboratoire Roger BeUon, Seine, France) were incubated separately 
for 30 min at 37°C,  then mixed and left for 45-60 mill at 37°C. After sedimentation of erythro- 
cytes,  the cells in the supernatant fluid were washed twice by centrifugation at  1000  rpm 1328  SURFACE ALLOANTIGENS OF  PLASMA CELLS 
for 10 min at room temperature and resuspended in Medium 199; about 90% of the nucleated 
cells in this final preparation were lymphocytes. (c) Peritoneal lymphocytes: Cells were col- 
lected from the peritoneal cavity by lavage with Medium 199 supplemented with 10%  fetal 
calf serum and heparin; after two washings in the same medium, the cells were resuspended 
in a concentration of 3 X  10?/ml in Medium 199 plus 20% fetal calf serum and then incubated 
in a flat-bottomed tissue culture flask for 10 min at 37°C. Under these conditions macrophages 
adhere to the glass surface while the lymphocytes remain unattached. After three or more 
transfers of the unattached cells to new culture vessels the final suspension comprised >90% 
lymphocytes; these were washed once in Medium 199 before use. 
Liver,  Kidney  and  Brain  Homogenates.--Tissues  from exsanguinated mice were  minced 
with curved scissors and gently homogenized in a Teflon tissue homogenizer (TRI-R Instru- 
ments, New York) in Earle's balanced salt solution (EBSS). After the large tissue fragments 
settled, the cells in the supernatant fluid were collected by centrifugation and washed three or 
more times to remove cell fragments that were not brought down by centrifugation for 10 min 
at 2000  rpm. The washed cells were then resuspended in  EBSS,  transferred to small glass 
tubes (6 X  50 ram), and centrifuged at 2000 rpm for 15 min. These pellets of packed cells 
were used for absorption of antiserum. 
Cytotoxic  Test.--Based  on  Gofer  and  O'Gorman  (12) with  modifications (13).  0.05  ml 
volumes of (a) cells  (5  X  106/ml),  (b) antiserum (serially  diluted), and (c) guinea pig serum 
(complement source, diluted 1:3 or 1:4) were incubated in (10  X  75 mm) tubes for 45  rain 
at 37°C. The proportion of dead cells was determined by adding 0.1 ml of 0.16C7c trypan blue 
to each tube. The dye stains dead cells but is excluded by living cells. 
Absorption  Test for Determining  the Presence or Absence  of an AnEgen.--See  reference 11. 
The cytotoxic end point of the relevant antiserum  (50%  cells dead)  is first determined by 
titration  (twofold  dilutions) against the most sensitive available test cell  (e.g. lymphocytes 
in the case of H-2 and thymocytes in the case of ~). A dilution one to two tubes below this is 
selected for the absorption tests. Equal volumes of washed packed cells or homogenized tissues 
are incubated for 30  rain at 4°C  with shaking. The absorbed antiserum is recovered after 
centrifugation in the cold and tested in serial dilution for residual cytotoxic activity against 
cells of the relevant type. 
EsEmation of the A mount of a Cell Surface A ntlgen by Quantitative A bsorption.--See  reference 
3.  Aliquots (0.06 ml)  of appropriately diluted antiserum (see preceding paragraph)  are ab- 
sorbed with a  series of counted numbers of the washed viable cells  to be tested, spanning 
the range from undetectable to complete absorption. The absorbed antiserum aliquots are 
then titrated with the appropriate test cell for residual cytotoxicity. The residual cytotoxic 
activity, expressed as per cent of cells stained, is plotted against numbers of cells used for 
absorption to give an absorption curve. The absorption index is the number of cells (n) indi- 
cated by the intersection of this curve with the level  of 50% cells dead. Thymocytes were 
included as the standard reference cells in every test, and the antigen content of other cells 
was expressed as per cent antigen content of thymocytes. 
n  (thymocytes) 
Antigen content (relative to thymocytes)  =  n  (cells being tested)  X  100 
Assays for q/M or "yG Plaque-Formlng  Cells (PFC).--Adult mice were injected intravenously 
with 0.2 ml of 20% washed sheep erythrocytes in EBSS; this was repeated 3 wk later in the 
case of the yG PFC assay. For ")'M-forming PFC assay (14) spleen cells were obtained on the 
4th day after primary immunization; 3,G-forming  PFC  were assayed according to Dresser 
and Wortis  (15) with rabbit anti-mouse "yG diluted 1:150  and spleen cells obtained 5 days 
after secondary immunization. 
Detection of Cell Surface  Antigens  on PFC.--The spleen cells were washed twice and sus- TOSHITADA  TAKAHASHI:,  LLOYD  J.  OLD:,  EDWARD  A.  BOYSE  1329 
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pended in Medium 199 containing 2% fetal calf serum. Tubes containing equal volumes (0.1 
ml) of:  (a)  cells  (approximately 1-2  X  106); (b)  antiserum diluted 1:10, or normal mouse 
serum; and  (c)  rabbit serum  2 diluted  1:15  (complement source)  or guinea pig serum  1:3 
(alternate complement source,  see Results), were  incubated together at 37°C for 45 min in 
serological  tubes. The cells in each tube were  then washed once,  resuspended in a  volume 
approximately 0.1 ml, and added to a single agar plate for assay of PFC (see above). 
RESULTS 
Section f 
Tests for H-2,  O,  TL, Ly-A,  Ly-B,  and MSLA  Antigens on BALB  Myeloma 
Cells.--The  three  ascites  myelomas  MOPC-70A,  MOPC-104E,  and  MPC-67 
TABLE  III 
Summary of Quantitative Estimations of O, Ly-A, and MSLA Antigens on BA LB 
Thymocytes, Lymphocytes, and Myeloma Cells 
Cells  0-C3H  Ly-A.2  MSLA  Amount of Antigens* 
%  %  % 
Normal BALB 
Thymocytes  100  100  100 
Lymph node ceils  25  66  46 
Spleen cells  16  55  25 
Blood lymphocytes  19  68  32 
Peritoneal lymphocytes  21  52  52 
BALB myeloma 
MOPC-70A  ) 
MOPC-104E t  <5  <5  <5 
MPC-67  j 
* Absorption capacity (see Fig. 2) relative to thymocytes (thymocytes content =  100%). 
were tested for sensitivity to antisera of all these six systems and were found to 
be resistant  to  all of  them  except  anti H-2.  BALB  thymocytes,  as  expected, 
were sensitive to  antisera of all six systems. Lymphocytes from spleen, blood, 
peritoneal cavity,  and thoracic duct were  sensitive to  all antisera except  anti 
TL.  Some representative results are illustrated in Fig.  1. 
Absorption of antibody from antiserum diluted to the region of the endpoint 
(see Methods)  is a  sensitive test for a  cellular antigen present in amounts too 
low to render the cell sensitive to immune cytolysis by the respective antibody 
and complement. Also according to this criterion all the antigens named above, 
with the exception of H-2, were absent from the three myeloma lines. In some 
instances,  quantitative  absorption  tests  were  performed  on  thymocytes, 
2 Footnote:  From  a  pool  of  serum  from  rabbits  selected  for  low  toxicity  to  mouse 
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lymphocytes from  various  sources,  and  the  three  myeloma  cells  (Fig.  2  and 
Table III). These results confirm the absence of all except H-2 from the three 
myeloma lines, the presence of all except TL on lymphocytes from all available 
sources, and the presence of all six antigens, without exception, on thymocytes. 
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Fro. 2.  Quantitative estimation of 8, Ly-A, and MSLA antigens on MOPC-70A myeloma 
cells, on thymocytes, and on lymphocytes from various sources. Conclusion: These antigens 
are not demonstrable  on MOPC-70A myeloma cells (illustrated here)  or on two other mye- 
lamas.  MOPC-104E  and MPC-67,  (not shown in this Figure).  Other absorption tests have 
given similar negative results for TL and Ly-B antigens. 
Section II 
The  PC.1  (Plasma  Cell 1)  Alloantigen  Defined by  the Serum  DBA/2  anti 
BALB Myeloma MOPC-7OA.--The formation of non-H-2  antibodies is some- 
times facilitated by the choice of an  H-2-compatible donor-recipient pair for 
immunization. This is why the antiserum DBA/2 anti BALB myeloma MOPC- 
70A was  included among  several immunizations performed during  the search 1332  SURFACE  ALLOANTIGENS  OF  PLASMA  CELLS 
for antigens peculiar to myeloma cells and normal plasma cells.  DBA/2  and 
BALB are both H-2  a and although they differ from Ly-A and Ly-B it was not 
anticipated that antibodies to these antigens would be formed, because neither 
is carried on the myeloma cells used for immunization (see Section I). In fact 
anti Ly-A.2 and anti Ly-B.2 were not elicited, as can be seen from Fig. 3, since 
no cytotoxic activity is present against BALB thymocytes and lymphocytes, 
but the antiserum was strongly cytotoxic for all three myelomas (Fig. 3). The 
specificity of this newly recognized reaction was  distinguished  from the leu- 
kemia-associated antigens G, FMR, ML, E, and TL by lack of cytotoxicity for 
the standard leukemias bearing these antigens which we maintain for typing 
purposes. 
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FIG. 3.  Cytotoxic activity of DBA/2 anti MOPC-70A serum. This antiserum is not cyto- 
toxic for thymocytes or lymphocytes; the specificity of the reaction against the myeloma 
lines is anti PC.1 alloantigen. 
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Absorption  tests  (Table IV)  showed the  antigen to  be present  on  all  five 
myelomas tested and also in some normal tissues of BALB mice: liver, kidney, 
brain, spleen, and, in lesser amount, lymph node cells. Absorption of anti PC. 1 
by liver, kidney,  and brain cannot be ascribed to their content of lymphoid 
cells  because  the  absorption  capacity  of  these  tissues  was  not  reduced  by 
massive  pretreatment  of  the  donors  with  corticosteroid  (Dexamethasone  4 
mg/kg per day for 5 days). Specificity is shown by lack of absorption by the 
same tissues of DBA/2 origin. BALB tissues which failed to absorb cytotoxic 
antibody,  and  which  therefore lack  the  antigen,  are  thymocytes, peritoneal 
lymphocytes,  blood lymphocytes, bone marrow  cells,  erythrocytes, two  leu- 
kemias, and an ascites sarcoma. 
Cytotoxicity cannot be attributed to reaction with the 3'1  immunoglobulin 
which  the  immunizing  myeloma MOPC-70A  produces  and  may bear  on  its 
surface because (a)  the strain distribution of the  antigen (Table V)  does not 
correspond to any known 3"1 allotype, (b) the serum of normal BALB mice or 
BALB  mice  bearing  MOPC-70A  did  not  neutralize  cytotoxic  antibody  or TO3HITADA TAKAHASHI, LLOYD  J.  OLD,  EDWARD  A.  BOYSE  1333 
precipitate with the antiserum, and (c) the antiserum was cytotoxic for BALB 
myelomas producing 3'A or 3'M as well as for the "yl-producing MOPC-70A. 
The typing of mice of various strains for the presence or absence of this new 
antigenwas done by absorption  with liver, a convenient  plentiful source, and test- 
ing the  absorbed serum against MOPC-70A cells, as illustrated in Table IV. 
TABLE  IV 
Tissue Representation o[ PC.1 Antigen Determined by Absorption of Cytotoxic Antibody 
DBA/2  anti MOPC-70A serum absorbed with: 
%MPOC-70A cells lysed 
by absorbed serum 
1:1"  1:2 
Result of 
absorption 
BALB myelomas 
MOPC-70A, MOPC-104E, MPC-67, MPC-11, or Adj-  < 10  < 10  + 
PC5 
BALB leukemias 
BALBCRL2, or BALBCSL2  >95  >80  -- 
BALB ascites sarcoma 
Meth A  >95  91  -- 
BALB normal tissues 
Liver or kidney homogenate  < 10  < 10  + 
Brain homogenate  23  < 10  + 
Spleen ceils  12  < 10  + 
Lymph node cells  73  37  4- 
Peritoneal or blood lymphocyte  --  >95:~  -- 
Cells from thymus or bone marrow; erythrocytes  >95  >95  -- 
DBA/2 normal tissues (negative control) 
Liver homogenate  >95  89  - 
Kidney homogenate  >95  78  -- 
Brain  homogenate; or  cells from thymus,  spleen or  >95  >95  -- 
lymph nodes; or erythrocytes 
Method:  0.2 ml DBA/2  anti MOPC-70A 1:20 incubated with 0.2 ml of packed, washed 
cells or tissue homogenate for 30 min at 4°C. 
* Residual cytotoxicity of absorbed serum tested against MOPC-70A cells without further 
dilution (1:1) or diluted 1:2. 
For peritoneal lymphocytes and blood lymphocytes (obtainable only in relatively small 
numbers) 0.06 ml of antiserum diluted 1:40 was absorbed with 107 cells. 
The strain distribution does not correspond with that of any known cell surface 
alloantigen or  serum  protein  allotype.  C3Hf/Bi  differs  from  C3H/An  and 
C3H/He, providing a  third serologically demonstrable antigenic difference be- 
tween these sublines, the other two being H-6 (17)  and the antigens specified 
by the mammary tumor virus. 
Typing of segregating progeny of backcross and F2 generation from a  cross 
between PC.I  + and PC.I- strains gave clear-cut positive or negative results for 
individual mice, and the ratios are characteristic of a single mendelian dominant 
gene (Table VI). We have designated the locus Pca  (plasma  cell antigen). 1334  SURFACE  ALLOANTIGENS  OF  PLASMA  CELLS 
Section III 
Tests for  PC.I,  H-2,  O,  Ly-A,  Ly-B,  and MSLA  Antigens  on  Normal  Im- 
munoglobulin-Forming  Cells.--Leukemia  cells  commonly  carry  the  normal 
surface antigens of the normal lymphoid cells from which they are descended. 
Thus  it  is  inferred  that  any normal antigens  expressed  on myeloma cells will 
also be expressed on normal plasma cells.  Accordingly it might be anticipated 
TABLE V 
Strain Distribution of PC.1 Antigen* 
PC.1  +  PC.l- 
C3H/An  C3Hf/Bi 
C3H/HeJ  C57BL/6 
A  C57BL/H-2 k (congenic) 
A/TL- (congenic)  C57BL/TL  + (congenic) 
A.SW  C57BL/Ly-A.1  (congenic) 
AKR  C57BL/Ly-B.1  (congenic) 
AKR/H-2 b (congenic)  B10.D2 (congenic) 
BALB/c  H-2I 
BALB/c-2  (congenic)  ~  H-2G 
NZB/B1  C58 
MA/J  CBA-T6 (Lyon) 
RF/J  DBA/2 
101  129 
SJL/J  I 
PL 
CE 
* Typing by absorption of DBA/2 anti MOPC-70A serum (anti PC.I) with washed liver 
homogenate; absorbed antiserum  tested for residual cytotoxicity  on MOPC-70A cells. Liver 
was chosen as the tissue for absorption because it provides a conveniently large amount  of 
material. 
Indicating  independence of the Pea and  Ig loci. BALB/c-2 mice (kindly provided by 
Dr.  Michael Potter)  differ from the congenic partner BALB/c by possessing the C57BL/6 
Ig heavy chain allot3~pe. (See reference 16.) 
that  normal  BALB  immunoglobulin-forming cells  will  express  H-2  and  PC.1 
antigen but not the characteristic lymphocyte differentiation  antigens because 
these latter  are known to be absent from myeloma cells  (Section II). 
This was verified by testing hemolytic plaque-forming cells (PFC)  of BALB 
spleen for their sensitivity to the relevant cytotoxic antisera.  For this purpose 
spleen  cells  from  BALB  mice  immunized  against  sheep  erythrocytes  were 
incubated  with  each  antiserum  in  the  presence  of complement  as  in  the  con- 
ventional cytotoxic test. After washing, the cells were tested for their capacity 
to produce hemolytic plaques in agar plates containing sheep erythrocytes (see 
Methods). H-2 antiserum was lethal for both "),M-producing and 3'G-producing 
PFC in the presence of guinea pig serum, but under the same conditions PC.1 TOSHITADA  TAKAIIASHI,  LLOYD  J.  OLD~  EDWARD  A.  BOYSE  1335 
antigen was demonstrable only on "gG-producing PFC (Table VII). It seemed 
unlikely that this distinction was genuine, for PC.1  antigen is carried by the 
3,M-producing  myeloma  MOPC-104E.  Accordingly  the  experiments  were 
repeated with guinea pig serum replaced by rabbit serum, which is known to be a 
superior source of complement in mouse cytotoxic assays (reviewed by Haugh- 
ton  and  McGehee,  18),  and  the  distinction was  no  longer  apparent  (Table 
VIII).  A  comparison of  Tables VII  and VIII provides a  remarkable further 
illustration of superior complementation by rabbit serum in comparison with 
guinea pig serum. 
TABLE  VI 
InYependent Segregation of H-2 and Pca Genes in Backcross and F2 Populations 
from the Cross C57BL (H-2b:PC.1  -) )< BALB (H-2d:PC.1  +) 
Population  PC.1  +  PC.l-  Total 
Backcross to C57BL 
H-2 a+  11  14  25 
H-2  d-  13  14  27 
Total  24  28  52* 
F2 generation 
H-2  do  5  4  9 
H-2 ba  17  3  20 
H-2 bb  9  2  11 
Total  31  9  40, 
"28  9 9  and 24 OZo  z . 
21  ?  9  and 19 oZoZ. 
To make sure that the suppression of PFC produced by anti PC.1 antiserum 
was not due to an unrecognized cytotoxin in the PC.1  antiserum DBA/2 anti 
MOPC-70A the following test of specificity was carried out: 
Progeny of a PC.1  + to PC.I- backcross were typed PC.1  + and PC,I- by absorption with 
liver  (see text  and Table V). The PC.I  + livers and the  PC.l- livers were then separately 
pooled and used to absorb two aliquots of anti PC.1 antiserum. The two absorbed antisera 
were then tested for anti PFC activity as in Table VIII. The antiserum absorbed with the 
PC.l- pool retained activity against both 3'G and 3'M PFC. The antiserum absorbed with 
the PC.1  + pool lost both activities. This shows that the anti PFC (both "),M and "yG) activity 
of DBA/2 anti MOPC-70A is due to anti PC.1. 
Anti PFC activity by anti PC.1  serum was weaker than by anti H-2 serum 
but there is no reason to attach more significance to this than a difference in the 
cytotoxic potency of the two antisera under the conditions obtaining. 
Antisera of  the four systems 0, Ly-A, Ly-B,  and MSLA  (anti TL was not 
tested) had no significant anti PFC activity. 1336  SURFACE ALLOANTIGENS OF  PLASMA CELLS 
~.~ 
~.~ 
~.~ 
N 
c~ 
sg  ~  R  N  ~° 
M 
°~  ~ 
~e 
m 
m 
~g 
~z 
C 
< 
~  ~-...~ o ~ 
o~ 
d~ 
v,.~ 
"~  o  •  -.  ra 
ca 
.~ 
~  ca 
-F  ~x 
-4 
~'  8.., .~, 
.~  .~ 
~'~  ~  ~ 
.~ 
=~ ~~ 
s  °  ~B 
r'~ TOSHITADA  TAKAHAStII~  LLOYD  J.  OLD~  EDWARD  A.  BOYSE  1337 
g 
A~ 
Ae 
g 
% 
i 
r~ 
~m 
N 
i 
z~ 
A 
b 
"3 
.) 
~  g 
"3 
~8  ~-~# 1338  SURFACE  ALLOANTIGENS  OF  PLASMA  CELLS 
DISCUSSION 
The cell which gives rise to the plasma cell is not absolutely identified. Four 
contenders  theft have  been  considered are  lymphatic reticular  cells  (19  21), 
lymphocytes (22-24), endothelial cells in the postcapillary venules of lymphatic 
tissue  (25),  and perivascular mesenchymal cells  (26).  The ancestral  cell,  not 
necessarily the immediate parent cell, is assumed to be a mobile cell of the bone 
marrow, for imnmnoglobulins of allogeneic radiation chimeras are of the donor 
type (27). 
A further indication of the cellular origin of plasma cells is the presence or 
absence of the cell surface antigens characteristic of lymphocytes. These include 
the  three  sets  of  alloantigens  (~,  Ly-A,  and  Ly-B)  and  the  species  antigen 
MSLA, which occur on all mouse lymphocyte populations (not necessarily on 
all individual lymphocytes) whatever their origin, whether from thymus, lymph 
nodes, spleen, peritoneal cavity, peripheral blood, or thoracic duct2 Leukemia 
cells often continue to express these differentiation antigens even after years of 
serial transplantation;  their presence is probably the most  certain indication 
that  a  given malignant  cell line  originated from  the  thymocyte-lymphocyte 
axis.  The probable  conclusion is  that  malignant  cell types  that  never carry 
these antigens do not originate from the  thymocyte-lymphocyte axis.  Conse- 
quently, their observed absence from the myelomas that we have studied implies 
that normal plasma cells do not carry them either. This conclusion is strength- 
ened by the  finding that plaque-forming cells,  both  -yG-producing and  -yM- 
producing,  are  insensitive  to  cytotoxic antisera  belonging  to  any  of  these 
systems and so must  lack these antigens. Therefore, either (a) the plasma cell 
does not belong to the thymocyte-lymphocyte axis but is derived from another 
type of lymphocyte (presumably from one lacking these antigens  or perhaps 
not from a lymphocyte at all)  or (b)  differentiation to a  plasma cell involves 
the lymphocyte in another metamorphosis of cell surface structure, added to 
that accompanying its  differentiation from  the  stem  cell,  with  all  that  this 
entails in the way of selective gene repression and derepression. Even granted 
a surface membrane turnover sufficiently rapid to transform the ph~notype, the 
former interpretation seems more probable, i.e., that the plasma Cell, whether 
or not derived from a cell with lymphocyte morphology, is not derived from a 
lymphocyte of the thymocyte-lymphocyte axis. 
The most likely alternative parent for the plasma cell is a lymphocyte of the 
postulated bursa-lymphocyte axis  in  birds  (28,  29),  and  of the  hypothetical 
equivalent system in other animals (30). This suggests that bursal lymphocytes 
of birds will  be found to have a  set of differentiation antigens  distinguishing 
them from thymic lymphocytes. Absence of the thymocyte-lymphocyte differ- 
3 In  unpublished  experiments with  Dr.  M.  Mandel,  we  found  that  thoracic  duct  cells 
react  like lymph node lymphocytes in tests with TL, 0, Ly-A, Ly-B,  and MSLA antisera. TOSIIITADA TAKAHASHI,  LLOYD  J.  OLD,  EDWARD  A.  BOYSE  1339 
entiation antigens from plaque-forming cells of mice favors this possibility, and 
so does the presence of PC.1  alloantigen on plasma cells,  which  distinguishes 
them  positively  from  thymocytes  and  from  at  least  a  large  proportion  of 
lymphocytes. 
SUMMARY 
A serological study of immunoglobulin-forming cells of the mouse, normal and 
malignant,  shows that they lack all known surface differentiation antigens of 
the thymocyte-lymphocyte axis: TL, 8, Ly-A, Ly-B, and MSLA. Two systems 
of  normal  alloantigens  are  expressed  on  these  cells,  H-2  and  a  new  system 
named PC. 
The gene Pca  (Plasma  cell antigen)  which  specifies PC.1  alloantigen segre- 
gates as a  mendelian dominant not closely linked  with  II-2.  This  cell  surface 
antigen is absent from thymocytes, leukemias, and very probably from thymus- 
derived lymphocytes also; it is present on cells of the liver, kidney, brain, and 
lymph nodes as well as on hemolytic plaque-forming cells of the spleen, and on 
myelomas. So PC.1  is  properly classified as  a  differentiation  alloantigen.  The 
strain distribution  of PC.1  does not  conform to that of any known immuno- 
globulin allotype or cell surface alloantigen previously described. 
Thus the cell surface antigens of immunoglobulin-producing cells are clearly 
different from those of cells belonging to the thymocyte-lymphocyte axis. Each 
family of  cells  has  distinctive  alloantigens,  and  the  two  families  share  allo- 
antigens  of  only  one known  system,  H-2.  This  implies that  either  immuno- 
globulin-producing  cells are not derived from thymic lymphocytes, or if they 
are, the program responsible for the transition must include extensive revision 
of cell surface structure. 
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